Dhaka, Bangladesh (BBN): The Dhaka Stock Exchange (DSE) board gave listing approval of the Orion Pharma that will hit the market very soon, officials said.
The approval came at a board meeting held on Wednesday at the DSE board room presided over by its president Rakibur Rahman.
Trading date of Orion Pharma will be announced soon, said a DSE official. “We will fix the trading date after transferring shares to respective BO (Beneficiary Owner) accounts,” he said.
Using a fixed-price method, Orion Pharma floated 40 million ordinary shares of BDT 10 each at an offer price of BDT 60, including a premium of Tk 50.
The company’s earnings-per share is BDT 5.57 and net asset value per share is BDT 76.86, according to its 2011 financial statements.
From 6-10th January Orion Pharma collected IPO application from resident Bangladeshi investors. NRB investors got 9 days more time to apply.
After finishing all process Initial Public Offering (IPO) lottery of Orion Pharma was held 7 February, 2013.
The Bangladesh Securities and Exchange Commission (BSEC) approved IPO prospectus of Orion Pharma 16 October last year.
BBN/BB/AD/07Mar-13-11.30am (BST).
